Joincare Pharmaceutical Group DRC (JCAREq)

Switzerland
Currency in USD
8.00
0.00(0.00%)
Closed·
JCAREq Scorecard
Full Analysis
Management has been aggressively buying back shares
Trading near 52-week High
Fair Value
Day's Range
8.008.00
52 wk Range
8.008.00
Key Statistics
Edit
Prev. Close
8
Open
8
Day's Range
8-8
52 wk Range
8-8
Volume
-
Average Volume (3m)
22
1-Year Change
0%
Book Value / Share
1.08
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
JCAREq Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Neutral
Moving Averages
Strong Sell

Joincare Pharmaceutical Group DRC Company Profile

Joincare Pharmaceutical Group Industry Co.,Ltd. engages in the research, development, production, and sale of pharmaceuticals and health care products in China. The company offers chemical pharmaceuticals for respiratory, gastroenterology, assisted reproduction, psychiatry, and anti-infection; chemical APIs and intermediates for drugs for humans and veterinary drugs; and traditional Chinese medicine, including cold medicine anti-viral granules and anti-tumor medicine. It also provides diagnostic reagents and equipment, such as mycoplasma pneumoniae IgM antibody test and antinuclear antibody test kit; OTC products which includes Taitai and Jingxin oral liquid, Eagle’s American ginseng tea, and Yike Tie; and biologics comprising tocilizumab and mouse nerve growth factor injection. The company was founded in 1992 and is headquartered in Shenzhen, China.

Employees
14350

Compare JCAREq to Peers and Sector

Metrics to compare
JCAREq
Peers
Sector
Relationship
P/E Ratio
15.5x28.0x−0.5x
PEG Ratio
−4.62−0.950.00
Price/Book
1.5x2.9x2.6x
Price / LTM Sales
1.4x4.1x3.1x
Upside (Analyst Target)
-17.0%46.1%
Fair Value Upside
Unlock10.3%6.9%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.73%
Dividend Yield
3.10%
Annualised payout
0.25
Paid annually
5-Years Growth
-
Growth Streak

Earnings

Latest Release
Apr 24, 2025
EPS / Forecast
0.23 / --
Revenue / Forecast
4.09B / --
EPS Revisions
Last 90 days

JCAREq Income Statement

FAQ

What Is the Joincare Pharmaceutical DRC (JCAREq) Stock Price Today?

The Joincare Pharmaceutical DRC stock price today is 8.00

What Stock Exchange Does Joincare Pharmaceutical DRC Trade On?

Joincare Pharmaceutical DRC is listed and trades on the Switzerland Stock Exchange stock exchange.

What Is the Stock Symbol for Joincare Pharmaceutical DRC?

The stock symbol for Joincare Pharmaceutical DRC is "JCAREq."

Does Joincare Pharmaceutical DRC Pay Dividends? What’s The Current Dividend Yield?

The Joincare Pharmaceutical DRC dividend yield is 3.1%.

What Is the Joincare Pharmaceutical DRC Market Cap?

As of today, Joincare Pharmaceutical DRC market cap is 2.98B.

What Is Joincare Pharmaceutical DRC's Earnings Per Share (TTM)?

The Joincare Pharmaceutical DRC EPS (TTM) is 0.73.

From a Technical Analysis Perspective, Is JCAREq a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.

How Many Times Has Joincare Pharmaceutical DRC Stock Split?

Joincare Pharmaceutical DRC has split 0 times.

How Many Employees Does Joincare Pharmaceutical DRC Have?

Joincare Pharmaceutical DRC has 14350 employees.

What is the current trading status of Joincare Pharmaceutical DRC (JCAREq)?

As of 12 July 2025, Joincare Pharmaceutical DRC (JCAREq) is trading at a price of 8.00, with a previous close of 8.00. The stock has fluctuated within a day range of 8.00 to 8.00, while its 52-week range spans from 8.00 to 8.00.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.